We are live on ! Find out more
PCM

Pathway Capital Management Portfolio holdings

AUM $4.3M
1-Year Est. Return 62.8%
This Fund
S&P 500
This Quarter Est. Return
+24.15%
1 Year Est. Return
+62.8%
3 Year Est. Return
+496.35%
5 Year Est. Return
+305.57%
10 Year Est. Return
–
AUM
$31.2M
AUM Growth
+$1.41M
Cap. Flow
-$5.19M
Cap. Flow %
-16.63%
Top 10 Hldgs %
100%
Holding
6
New
2
Increased
–
Reduced
–
Closed
3

Top Buys

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$8.57M
2
DUOL icon
Duolingo
DUOL
+$899K

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.35M
2
LZ icon
LegalZoom.com
LZ
+$5.87M
3
NN icon
NextNav
NN
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 74.12%
2 Healthcare 25.88%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOST icon
1
Toast
TOST
$17.5B
$22.2M 71.3%
1,168,871
– –
DAWN
2
DELISTED
Day One Biopharmaceuticals
DAWN
$8.07M 25.88%
+403,127
New +$8.57M
DUOL icon
3
Duolingo
DUOL
$6.28B
$880K 2.82%
+9,236
New +$899K
DDOG icon
4
Datadog
DDOG
$93.9B
– –
-77,176
Closed -$7.35M
LZ icon
5
LegalZoom.com
LZ
$1.31B
– –
-533,724
Closed -$5.87M
NN icon
6
NextNav
NN
$1.81B
– –
-636,261
Closed -$1.44M

Similar funds

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
KAM
Kirkoswald Asset Management New York $5.23M AUM
FWA
FSC Wealth Advisors Fishkill, New York $5.24M AUM 17.32% 1-Year Est. Return
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return

Pathway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Pathway Capital Management held 6 positions worth $31.2M, up 4.7% from $29.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pathway Capital Management withdrew a net $5.19M in Q3 2022, closing 3 positions. Its most notable exit was Datadog, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Technology at 74% of assets, down from 80% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Pathway Capital Management opened a new position in Day One Biopharmaceuticals worth $8.07M.

  • Pathway Capital Management's largest Q3 2022 buy was Day One Biopharmaceuticals: 403,127 shares worth $8.07M.
  • Pathway Capital Management fully exited Datadog in Q3 2022, selling an estimated $7.35M.
  • Pathway Capital Management's ten largest holdings make up 100% of its $31.2M portfolio in Q3 2022.
  • Pathway Capital Management opened 2 new positions and closed 3 in Q3 2022.
  • Pathway Capital Management's portfolio value rose 4.7% quarter-over-quarter to $31.2M.

Based on Pathway Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.